OA01.03 Attrition Rate in Community-Based Lung Cancer Screening: One and Done
Journal of Thoracic Oncology, ISSN: 1556-0864, Vol: 12, Issue: 11, Page: S1549-S1550
2017
- 8Usage
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage8
- Abstract Views8
- Captures1
- Readers1
Abstract Description
Background Community-wide lung cancer screening has the potential to significantly impact lung cancer mortality. Thus, much emphasis has been placed on program development and recruitment of high-risk individuals. Lung cancer screening is a continuum, and shared decision-making focuses on the need for participants to remain engaged. Currently, little is known about screening follow-through in the community setting outside of clinical trials. Thus, we aimed to quantify the rate of attrition in our Lung Cancer Screening Program (LCSP) and identify contributing factors. Methods We reviewed all individuals enrolled in our LCSP, which is led by an independently practicing nurse practitioner within a multidisciplinary team, from 2012-2016. We identified all individuals who were closed out of the program, the closure date, and reason for closure. Of these, attrition was defined as declined further screening or lost to …
Bibliographic Details
https://digitalcommons.providence.org/publications/8939; https://digitalcommons.providence.org/publications/7548
http://www.sciencedirect.com/science/article/pii/S1556086417307396; http://dx.doi.org/10.1016/j.jtho.2017.09.005; https://linkinghub.elsevier.com/retrieve/pii/S1556086417307396; https://api.elsevier.com/content/article/PII:S1556086417307396?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S1556086417307396?httpAccept=text/plain; https://digitalcommons.providence.org/publications/8939; https://digitalcommons.providence.org/cgi/viewcontent.cgi?article=9673&context=publications; https://digitalcommons.providence.org/publications/7548; https://digitalcommons.providence.org/cgi/viewcontent.cgi?article=8309&context=publications; https://dx.doi.org/10.1016/j.jtho.2017.09.005
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know